Aug 7-9, 2020 | LIVE VIRTUAL EDITION

ATTEND FROM ANYWHERE!

Vision2O2O

Seeing the Opportunities

Florida Society ofHealth-System Pharmacists

ProgramSubject To Change

54TH Annual Meeting

A Year of Opportunity and Growth

While COVID-19 has stolen the limelight for now, it has not stolen our resolve and determination to move our Society and profession forward. One year ago, I delivered a message of excitement and optimism for creating new opportunities and building on our past success. I am proud to report that we have had an outstanding year that can only be achieved with collaboration, teamwork, and determination!

First, I would like to thank an amazing Executive Committee, Board of Directors, Council Chairs, Vice Chairs, Regional Society Officers, FSHP members, and our phenomenal FSHP Staff for a successful year. We simply would not be successful without the hard work, commitment, and dedication of all of you!

I am extremely happy to report that after years of advocating for collaborative practice, we have broken through to achieve this critically important legislation. With the passage of HB599 and HB389, the Florida legislature made it loud and clear we want pharmacists more involved with caring for our patients! It now states in the Florida statutes that pharmacists in collaboration with a physician, may initiate, modify, and discontinue drug therapy. This is a significant step towards pharmacists being reimbursed for direct patient care services in Florida. I would like to thank the tireless resolve of past president Kathy Baldwin, the support of our Legal & Regulatory Affairs Council, the invaluable guidance of our lobbying team at Gray Robinson, and the many FSHP members who have helped in this endeavor over the last several years.

It also must be recognized the significant impact of our Political Action Committee toward achieving collaborative practice. Our PAC – Pharmacists for Improved Health Care Outcomes - has helped build our presence in Tallahassee by strengthening our relationships with legislators who are friendly to the pharmacy profession. I want to thank you for your support and encourage you to continue giving towards to our PAC. It is the single best way you can support our legislative agenda.

In addition to our legislative efforts, we have been working to create long term growth and success for FSHP. Our Board has crafted a new Vision and Mission Statement that represents who we are as a Society and guides FSHP in everything we do. Our new vision is to be the leader in ensuring every patient has optimal medication therapy outcomes and our new mission is to advance the pharmacy profession through leadership, education, and practice innovation. FSHP joined state leaders and ASHP in taking a position for major issues that affect our profession and the patients.

FSHP created one new Council and two Clinical Forums to grow opportunities for FSHP members to participate, grow professionally, and build value. We created a Communications Council which will focus on additional educational content provided through electronic mediums such as YouTube, Twitter, Linked In, and other social media platforms. We created an Infectious Diseases and Ambulatory Care Clinical Forums for pharmacists across Florida to network, discuss latest practice trends, and work towards producing educational content. I encourage you to sign up and get involved in one of our many Councils and new forums.

As COVID-19 hit, FSHP worked to support pharmacists across Florida help manage through the crisis. We worked with ASHP to give feedback to the FDA on crucial shortages, provided several educational COVID-19 webinars, and worked with Regional Societies to move their education to a virtual platform.

Even with COVID-19, FSHP continues to be on solid financial footing. We completed our first comprehensive audit by an independent auditing firm with no significant issues. Our membership continues to grow, and while COVID-19 will impact our Annual Meeting, we will return next year with another amazing meeting!

Finally, the Councils on Educational Affairs, Legal and Regulatory Affairs, Member Affairs , Technician Affairs and Professional Affairs all achieved the charges they were given. The members of the Councils worked hard to ensure that FSHP’s term goals were met.

I end this year as humbly as I began this time last year, thanking you again for allowing me the opportunity to serve this organization.

Sincerely,

William Kernan, Pharm.D., MBA, FASHP

A Message From The FSHP President...

The FSHP Annual Meeting programming has been designed to enhance the knowledge, skills, and abilities of pharmacists and associated personnel in healthcare settings as we focus on important issues relevant to contemporary pharmacy practice.

T A The FSHP Annual Meeting programs were developed to meet the needs of pharmacists and pharmacy technicians in a variety of

practice settings.

G C.E.

The Florida Society of Health-System Pharmacists, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The continuing education programs for this meeting are Application and Knowledge-

Based Continuing Pharmacy Education (CPE) activities, which means that information that is provided will be in at least 60 minute lectures or presentations of facts that participants should be able to apply by means of learning assessment questions.

6.0 hours max of C.E. for Pharmacists and Pharmacy Technicians on Friday, August 7, 2020 6.0 hours max of C.E. for Pharmacists and 7.0 hours max of C.E. for Pharmacy Technicians on Saturday, August 8, 2020

3.0 hours max of C.E. for Pharmacists and Pharmacy Technicians on Sunday, August 9, 2020

The Florida Society of Health-System Pharmacists is approved by the Florida Board of Pharmacy as a provider of Consultant License Re-Certification, Validation of Prescription for Controlled Substances C.E.

CEBroker Course Tracking #: 20-705727 and 20-7824546.0 hours max of CRC C.E. on Friday, August 7, 2020

2.0 hours of Controlled Substances on Friday, August 7, 2020

6.0 hours max of CRC C.E. on Saturday, August 8, 2020

3.0 hours max of CRC C.E. on Sunday, August 9, 2020

C C /M E Attendance will be verified by virtual tracking upon entering into a Track/Session. 50 minutes of attendance will be required for

credits to be issued. Immediately following the meeting you will receive a link to an Electronic Evaluation and Course Verification Form. Completion of this form is REQUIRED. We thank you in advance for your constructive and appropriate responses.

Upon completion of the electronic Evaluation of Course Verification Form, C.E. will be processed and uploaded into CE Broker and CPE Monitor 4-5 weeks after the conclusion of the program. Meeting attendees must provide an NABP eProfile ID and month and

date of birth to receive C.E. credits. Sign up for your ID at www.nabp.net

P D S FSHP requires faculty, planners and other individuals who are in a position to control the content of continuing education activities

to disclose to the audience any real or apparent conflict of interest related to the activity. All identified conflicts of interest are thoroughly reviewed by FSHP to ensure fair balance, objectivity, and scientific rigor in all educational activities. FSHP maintains all disclosure information from all presenters of FSHP sponsored educational programs, including speakers and poster abstract authors.

ACPE N -C S The ACPE Standards for Commercial Support adopted in 2007 from ACCME require complete separation of continuing education

and promotion. Instructional materials for C.E. activities, including presentation slides, undergo an intensive review process by FSHP to ensure compliance with the Standards for Commercial Support. Disclosures of relevant financial interest by speakers have

been included on slides or will be announced in sessions, and in accordance with these Standards, any actual conflicts of interest were resolved prior to the C.E. activity taking place.

Continuing Education

7:30am 8:00am

ATTENDEES START LOGGING IN TO SESSIONS WELCOME—FSHP President, Bill Kernan, Pharm.D., FASHP

Moderators: Nicole Reardon, Pharm.D., BCPS, FCCM, John Allen, Pharm.D., BCPS, BCCCP, FCCM, Sheldon Lefkowitz, RPh

8:15-10:15am 2 hours of GCE/CRC/Tech/CS for pharmacists and technicians ACPE UAN 0163-0000-20-087-L04-P/THow Many Pharmacists Can Dance on the Head of a Pin? Balancing Access to Controlled Substances with Prevention of MisuseSpeaker 1: William Allen, Juris Doctor Shands Chair of Medical Ethics and History of Medicine, UF Colleges of Pharmacy and Medicine, Melrose, FL Speaker 2: Scott Coon, Pharm.D. Assistant Professor, University of South Florida Taneja College of Pharmacy, Tampa, FL Pharmacist and Technician Objectives: Describe the challenges encountered in hospitals, clinics, and health systems related to preventing and detecting

controlled substance diversion. Review current statistics and relevant aspects of the opioid drug epidemic. Discuss the importance of educating patients of the proper use storage and disposal of controlled substances. Discuss the role of the pharmacist in addressing the opioid overdose epidemic including opioid stewardship, harm

reduction, and opioid use disorder treatment. Discuss the pharmacist’s role in counseling patients on buprenorphine for opioid use disorder. Review available resources for opioid misuse and addiction. Review evidence-based harm reduction strategies including overdose training/naloxone distribution, FL syringe

exchange programs under §381.0038, and fentanyl testing. Discuss the responsibilities of pharmacists to prevent and detect controlled substance misuse while ensuring

appropriate access for all patients with valid prescriptions Identify clinical tools/automated processes to detect drug diversion, including use of the Prescription Drug

Monitoring Program database Summarize the process for ensuring controlled substance prescriptions are legitimate and have therapeutic value. Update and review current federal, and state regulatory standards relating to controlled substances Evaluate methods for addressing and resolving issues recognized during drug utilization reviews in regard to

controlled substances

10:15-10:30am Break

10:30-11:30am 1.0 hour of GCE/CRC/Tech for pharmacists and technicians ACPE UAN 0163-0000-20-088-L03-P/T Law Update and Panel Discussion Speaker 1: Kathy Baldwin, BS Pharm, Pharm.D., MA, BCPS Critical Care Pharmacist Practitioner, Baptist Medical Center South, Jacksonville, FL Speaker 2: Dorinda Segovia, Pharm.D. Vice President, Pharmacy Services, Memorial Healthcare System, Hialeah, FL Panelist: Joseph Salzverg, Gray Robinson Panelist: Rheb Harbison, Gray Robinson Pharmacist and Technician Objectives: Discuss activity from the last legislative session that may affect health-system pharmacists or pharmacies. Review activities of the Board of Pharmacy that may affect health-system pharmacists or pharmacies. Describe steps to improve member engagement in legislative advocacy.

11:30am-1:50pm Lunch Break Attendees start to log back in at 1:50pm

M

eeti

ng

Age

nd

a

F

rid

ay, A

ugu

st 7

, 20

20

PHARMACY LEGAL AND REGULATORY TRACK 3.0 HOURS OF C.E.

Moderators: Nick Scaturo, Pharm.D., Nicole Reardon, Pharm.D., BCPS, FCCM

2:00-3:00pm 1.0 hour of GCE/CRC/Tech for pharmacists and technicians ACPE UAN 0163-0000-20-089-L01-P/TTrauma Alert! The UN-Usual Suspects Speaker: Ruben Santiago, Pharm.D. Clinical Hospital Pharmacist, Emergency Medicine, Jackson Memorial Hospital, Ft. Lauderdale, FL Pharmacist Objectives: Review basic principles regarding care of the acutely injured patient. Discuss the role of the pharmacist during trauma resuscitation. Examine the evidence surrounding appropriate dosing recommendations for obese trauma patients. Outline the pharmacologic management of pregnant trauma patient. Summarize the evidence regarding appropriate medication selection in patients with myasthenia gravis.Technician Objectives: Recognize differences in dosing recommendations for obese patients. Describe management of the pregnant trauma patient in the emergency department. List common medications to avoid in patients with myasthenia gravis.

3:05-4:05pm 1.0 hour of GCE/CRC/Tech for pharmacists and technicians ACPE UAN 0163-0000-20-090-L01-P/TNope Ropes and Danger Noodles: An Update in the Management of Snake Envenomation Speaker: Fred Aleguas, BS Pharm, Pharm.D. Managing Director, Florida Poison Information Center-Tampa, Tampa, FL Pharmacist Objectives Review the clinical manifestations of North American snake envenomations. Compare and contrast the pharmacology, indications, and cost of the available Crotalidae immune fab products. Appraise literature surrounding the treatment of various types of snake envenomations. Develop evidence-based strategies for managing Crotalidae and Elapidae envenomations.Technician Objectives: Review the clinical manifestations of North American snake envenomations. Recall the antivenin treatment options for Crotalidae and Elapidae envenomations. Outline the process for preparation of snake antivenin products.

4:05-4:15pm Break

4:15-5:15pm 1.0 hour of GCE/CRC/Tech for pharmacists and technicians ACPE UAN 0163-0000-20-091-L04-P/TDooms Day Prep in the Emergency Department Speaker: Kara Birrer, Pharm.D., BCPS Clinical Pharmacy Specialist, Neurocritical Care, Orlando Regional Medical Center, Orlando Health, Orlando, FL Pharmacist Objectives: Outline the role of hospital and health system pharmacy in emergency preparedness and response. Describe the role of the emergency medicine pharmacist during a mass casualty event. Discuss the development of a pharmacy department policy and procedure for both planned and unplanned emergencies. Recognize the different medications and supplies needed for different types of emergencies. Review community resources and training available to assist with hospital planning & logistics.Technician Objectives: Describe the role of the pharmacy technician during a mass casualty event. Identify medications potentially utilized during a mass casualty event. Review community resources and training available to assist with hospital planning and logistics.

EMERGENCY MEDICINE TRACK 3.0 HOURS OF C.E.

Moderators: Ashley Lipscomb, Pharm.D., CPh, Angelica Berni, Pharm.D., MS, BCPS

2:00-3:00pm 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-092-L04-PPharmacist Burnout: What is Fanning the Flame and How Can We Extinguish It? Speaker: Heather Hardin, Pharm.D., BCACP Clinical Pharmacist, Health and Wellness Advocate, Halo Health Systems, Gainesville, FL Pharmacist Objectives: Determine the perception of burnout among health-system pharmacy department associates. Identify symptoms associated with burnout within the pharmacy setting. Explain the impact of clinician burnout on patient care and the pharmacy workforce. Discuss how to communicate burnout among the pharmacy team and with the pharmacist. Identify validated tools to measure burnout and apply them to the pharmacist and technician workforce. Illustrate an appropriate treatment for pharmacy staff burnout and prevention strategies to improve well-being and

resilience. Understand the implications burnout has on patient care.

3:05-4:05pm 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-093-L04-PEngaging in Crucial Conversations: The Mission and The Vision Speaker: Margaretta L. Kearson, Pharm.D. Clinical Pharmacy Manager, Memorial Regional Hospital, Hollywood, FL Pharmacist Objectives: Define the concept of crucial conversations utilizing current literature. Review techniques to resolve difficult situations. Identify characteristics of high, medium, and low performers. Illustrate practical strategies to engage in crucial conversations with all types of performers.

4:05-4:15pm Break

4:15-5:15pm 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-094-L04-PAchieving and Sustaining USP 800 Compliance Speaker: Lilit Smith, Pharm.D., MBA Manager, Compounding and Compliance, Baptist Health South Florida, Pembroke Pines, FL Pharmacist Objectives: Review the requirements for hazardous drug disposal and spill management. Discuss key components of USP 800 that impact Pharmacy practice. Explain USP 800 recommendations on environmental sampling and medical surveillance.

FUNDAMENTAL PRINCIPLES TRACK 3.0 HOURS OF C.E.

M

eeti

ng

Age

nd

a

F

rid

ay, A

ugu

st 7

, 20

20

7:30am ATTENDEES START LOGGING IN TO SESSIONS

Moderators: William Carothers, Pharm.D., Jennifer Hanify, Pharm.D., BCCCP

8:00-9:00am 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-20-095-L01-PThe “Status” of Refractory Status Epilepticus Management Speaker: Stacy Voils, Pharm.D., M.Sc. Clinical Associate Professor, University of Florida College of Pharmacy, Gainesville, FL Pharmacist Objectives: Review the definition and presentation of status epilepticus. Describe antiepileptic agents used in status epilepticus. Discuss treatment strategies for refractory status epilepticus. Explain the process of weaning patients off sedatives and antiepileptics.

9:05-10:05am 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-096-L01-POptimizing the Use of Antiplatelet Agents in Acute Coronary Syndrome Speaker: Otsanya Ochogbu, Pharm.D. Clinical Pharmacist Specialist, Advent Health Orlando, Winter Park, FL Pharmacist Objectives: Compare antiplatelet agents and treatment durations for ACS patients post-PCI and CABG.• Discuss antiplatelet bridging strategies between PCI and CABG.• Explain antiplatelet management options in patients with recent PCI experiencing majorbleeding.10:05-10:15am Break

10:15-11:15am 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-097-L01-PThe Critical Keys to Managing the Transplant Patient in the ICU Speaker: Andrew Silverman, Pharm.D. Pharmacotherapy Specialist in Abdominal Transplantation, Tampa General Hospital, Tampa, FL Pharmacist Objectives: Understand the interplay of common diseases seen in the critically ill transplant patient. Design a management strategy for treating rejection in the critically ill patient. Describe tools for monitoring and assessment of the critically ill transplant patient illness. Discuss alternative routes of administration of immunosuppressive agents in the NPO patient. Recognize the pharmacokinetic and pharmacodynamic interactions between immunosuppressive agents and medi-

cations used to manage the critically ill transplant patient.

11:15am-1:20pm Lunch Break Attendees start to log back in at 1:20pm

CRITICAL CARE TRACK 3.0 HOURS OF C.E.

Meetin

g Agen

da

Saturd

ay, Au

gust 8

, 20

20

Moderators: Kevin Olson, Pharm.D., Farima, Fakheri Raof, Pharm.D., BCPS, DPLA, 340B-ACE

8:00-9:00am 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-098-L01-P Finding the Sweet Spot: Emerging Treatments and Technologies in Diabetes Management Speaker 1: Amy Henneman, Pharm.D. Associate Professor Pharmacy Practice – Ambulatory Care, Palm Beach Atlantic, Jupiter, FL Speaker 2: Jordan Sedlacek, Pharm.D. Assistant Professor, Larkin University College of Pharmacy, Hollywood, FL Pharmacist Objectives: Distinguish between various continuous glucose monitoring (CGM) systems.

Develop a treatment plan for a patient with diabetes, taking into consideration information obtained from a patientutilizing a CGM system.

Design a treatment plan for a patient needing to convert between biosimilar or concentrated insulin products.

Apply current literature regarding cardiovascular and renal outcomes to the use of newer medication classes in themanagement of a patient with diabetes mellitus.

9:05-10:05am 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-099-L04-P Transitions of Care – Discharging Patients with Chronic Disease States Speaker 1: Tim L’Hommedieu, Pharm.D., MS Director of Pharmaceutical Services, BayCare Health System, Tampa, FL Speaker 2: Lauren Verbosky, Pharm.D., MS Ambulatory Pharmacy Manager, BayCare Health System, Tampa, FL. Pharmacist Objectives: Discuss the impact of readmissions on hospital quality and financials. Explore opportunities for pharmacy to impact readmissions through transitions of care services. Review method for scaling a Pharmacy Transitions of Care Program. Discuss success and challenges of a formal Pharmacy Transitions of Care Program.

10:05-10:15am

10:15-11:15am 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-100-L04-PBilling Mechanisms for Pharmacists’ Clinical Services: Emerging Opportunities Speaker: Dan Buffington, Pharm.D., MBA, FAPhA President and CEO, Clinical Pharmacology Services, Tampa, FL Pharmacist Objectives: Analyze the pharmacy profession and the evolution of clinical practice roles. Contrast different reimbursement models for pharmacists’ clinical services. Design advanced pharmacy practice models that incorporate the critical elements of business, innovation, and entre

preneurial skill.

11:15am-1:20pm Lunch Break Attendees start to log back in at 1:20pm

AMBULATORY CARE TRACK 3.0 HOURS OF C.E.

Mee

tin

g A

gen

da

Sat

urd

ay, A

ugu

st 8

, 20

20

Moderators: Anessia Ellerson, CPhT, RPhT and Sandra Barnes, CPhT, RPhT

8:00-9:00am 1.0 hour of GCE for technicians ACPE UAN 0163-0000-020-101-L04-TReducing Readmissions Through Medication Reconciliation Speaker 1: Katherine Vogel Anderson, Pharm.D., BCACP Associate Professor, University of Florida Colleges of Pharmacy and Medicine, Gainesville, FL Speaker 2: Petra Fallaha, AA Medication History Technician, Baptist South, Jacksonville, FL Technician Objectives: Discuss evaluation scales used to evaluate patients at risk for readmission. Identify pharmacy’s impact on reducing readmissions through medication reconciliation. Define the role of the pharmacy technician in medication reconciliation. Define the pharmacist’s role in medication reconciliation. Provide two case studies to illustrate the care transition from the inpatient to outpatient setting. Highlight best practices in medication reconciliation.

9:05-10:05am 1.0 hour of GCE for technicians ACPE UAN 0163-0000-020-102-L04-TPart 1: Advanced Roles with Pharmacy Technicians: Research Pharmacy Speaker 1: J. Michael Hayes, Pharm.D. Pharmacotherapy Specialist, Investigational Drug Service, Tampa General Hospital, Tampa, FL Technician Objectives: Describe the role of pharmacy technician in an investigational drug service. Understand the steps necessary for dispensing an investigational drug. Describe how an investigational drug is different from an FDA approved medication. Discuss the various inventory management, shipping and receiving practices that are specific to investigational drugs.

Part 2: Pharmacy Technician Training Programs: The Education Doesn’t Stop Here Speaker 2: Amanda Teckenbrock, CPhT, RPhT Pharmacy Technician Training Program Coordinator, Lee Health, Lehigh Acres, FL Technician Objectives: Describe advanced roles and education for pharmacy technicians. Describe how to start a pharmacy technician program. Discuss ways to advance as a pharmacy technician.

10:05-10:15am

10:15-11:15am 1.0 hour of GCE for technicians ACPE UAN 0163-0000-020-103-L04-TAdvanced Roles with Pharmacy Technicians: 340B/Pharmacy Buyer Speaker 1: James Moye, CPhT 340B Program Coordinator, Orlando Health, Orlando, FL Speaker 2: Jennifer Stewart, BA, Applied Science Business and Organizational Management Pharmacy Purchaser, Ocala Health/HCA Inc. Ocala Regional Medical Center, Ocala, FL Technician Objectives: Review the impact of 340B requirements on pharmacy purchasing and inventory. Discuss regulatory requirements impacting purchasing, receipt, and inventory management. Define the role of a pharmacy purchaser in managing medication shortages.

11:15am-12:15pm 1.0 hour of GCE for technicians ACPE UAN 0163-0000-020-104-L04-TSterile Compounding: What’s Happening Now? New Updates with USP 797 and USP 800 Speaker 1: Elizabeth Lewallen, CPhT Pharmacy Technician Supervisor, North Florida Regional Medical Center, High Springs, FL Speaker 2: Lori Fiallo, Pharm.D. Pharmacy Operations Manager, Baptist Health-Jacksonville, Ponte Vedra, FL Technician Objectives: Review state and regulatory agency standards for sterile compounding. Discuss the requirements for cleaning Aseptic compounding areas and the difference between hazardous and non-

hazardous areas including new requirements for personal protective equipment use. Describe best practices for ongoing monitoring for cleanroom practices.

PHARMACY TECHNICIAN TRACK 4.0 HOURS OF C.E.

Moderators: Kathryn Hernando, Pharm.D., Stephanie Brown, Pharm.D., BCPS

1:30-2:30pm 1.0 hour of GCE/CRC/Tech for pharmacists and technicians ACPE UAN 0163-0000-020-105-L01-P/TExpanding the View of Inpatient Stewardship: A Focus on Antiretrovirals Speaker: Kristy Shaeer, BA, Pharm.D., MPH Assistant Professor, University of South Florida College of Pharmacy, Tampa, FL Pharmacist Objectives: Identify the need for antiretroviral stewardship in the hospital setting. Describe antiretroviral stewardship program development, including key components, stakeholders, goals, and

strategies for achievement of goals. Outline best practice initiatives implemented by antiretroviral stewardship programs.Technician Objectives: Identify the need for antiretroviral stewardship in the hospital setting. Discuss the potential impact of antiretroviral stewardship in the hospital setting. Recognize best practice initiatives implemented by antiretroviral stewardship programs.

2:35-3:35pm 1.0 hour of GCE/CRC/Tech for pharmacists and technicians ACPE UAN 0163-0000-020-106-L01-P/TAntibiotic Stewardship in the ED: Shifting Focus Past Sepsis Speaker: Rachel Meyer, Pharm.D., BCPS Emergency Department Advanced Clinical Pharmacist, Gulf Coast Regional Medical Center, Panama City Beach, FL Pharmacist and Technician Objectives: Identify areas where pharmacists can have an impact on Antibiotic Stewardship in the Emergency Department. List steps for implementation of a pharmacist led out-patient culture follow up program. Given a patient case, design an appropriate follow up regimen for a discharged patient from the ED.

3:35-3:45pm Break

3:45-4:45pm 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-107-L04-PImplementation of Rapid Diagnostic Testing: Developing a Perspective Speaker: Kristen Zeitler, B.S., Pharm.D., BCPS Pharmacotherapy Specialist- Infectious Diseases, Tampa General Hospital, Tampa, FL Pharmacist Objectives: Evaluate literature supporting the use of rapid diagnostic testing and laboratory markers within an antimicrobial

stewardship program. Relate strategies for evaluation of cost and clinical benefits of rapid diagnostic testing. Develop criteria for patient selection for rapid diagnostic testing. Create a process for assessment and monitoring the impact of rapid diagnostic testing on the antimicrobial stewardship

program.

INFECTIOUS DISEASES TRACK 3.0 HOURS OF C.E.

Mee

tin

g A

gen

da

Sat

urd

ay, A

ugu

st 8

, 20

20

Moderators: Barry Bleidt, Pharm.D. and Brittany Herring, Pharm.D., MBA, CPh

1:30-2:30pm 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-108-L04-PGuide to Transformative Pharmacy Practices Speaker: Kevin B. Sneed, Pharm.D. Senior Associate Vice-President, USF Health, Dean and Professor, College of Pharmacy, University of South Florida, Tampa, FL Pharmacist Objectives: Review evolving healthcare systems and the positioning of the pharmacy profession within these systems. Discuss proposed new clinical reimbursement models for pharmacists. Discuss the role of pharmacists in shared risk / capitated contracting in an evolving healthcare system.

2:35-3:35pm 1.0 hour of GCE/CRC for pharmacists ACPE UAN 0163-0000-020-109-L04-PCoding, Population Health, and Finances: The NextGen Pharmacist Speaker: Renee Jones, Pharm.D., CPh Director of Pharmacy, Personal Physician Care, Miramar, FL Pharmacist Objectives:

Assess how population health and quality benchmark measures financially impact a medical organization. Educate pharmacists on Current Procedural Technology (CPT) codes that can be used by without provider status. Describe how Accountable Care Organizations (ACOs) and Management Services Organizations (MSOs) can reduce

health care costs and improve the quality of care. Identify numerous areas in which pharmacists have affected patient outcomes and cost savings using population health

data. Discuss Medicare endorsed clinical programs that pharmacists can offer primary care provider using a financial pro forma.

3:35-3:45pm Break

3:45-4:45pm 1.0 hour of GCE/CRC/Tech for pharmacists and pharmacy technicians ACPE UAN 0163-0000-020-110-L04-P/TLeadership: Developing People and Growing Careers Speaker 1: Dorinda Segovia, Pharm.D. Vice President, Pharmacy Services, Memorial Healthcare System, Hialeah, FL Speaker 2: Steve Allison, Pharm.D. Executive Director of Pharmacy, AdventHealth Orlando, Winter Garden, FL Pharmacist and Pharmacy Technician Objectives: Developing People Discuss methods on how to build a strategically planned, effective team and create a learning culture. Develop and apply strategies to advance pharmacy services through staff engagement, customer feedback, and effective

personnel management.Growing Careers Evaluate personal opportunities for self-development and improvement to optimize leadership effectiveness. Build and leverage key relationships within the organization among colleagues and senior leadership. Discuss strategic planning to advance practice and staff role development.

LEADERSHIP AND ADMINISTRATION TRACK 3.0 HOURS OF C.E.

Moderators: Cher Enderby, Pharm.D., BCPS, BCNSP, Shivana Syne, Pharm.D.

9:00-10:00am 1.0 hour of GCE/CRC/Tech for pharmacists and technicians ACPE UAN 0163-0000-020-111-L04-P/TWorkplace Aggression in Healthcare Speaker: Joshua Caballero, Pharm.D., BCPP, FCCP Professor and Chair, Department of Clinical Administrative Sciences, Larkin University, Plantation, FL Pharmacist and Technician Objectives: Discuss the definition and types of workplace violence. Identify risk factors for violence and responses to risk factors specific to the healthcare industry. Outline components of a workplace violence prevention program and strategies for implementation.

10:05-11:05am 1.0 hour of GCE/CRC/Tech for pharmacists and technicians ACPE UAN 0163-0000-020-112-L04-P/TMental Health in Healthcare Workers Speaker: Jose Rey, Pharm.D. Professor, Nova Southeastern University College of Pharmacy, Hollywood, FL Pharmacist and Technician Objectives: Increased awareness of the prevalence and risks of mental health issues in healthcare workers. Recognition of the signs and symptoms of mental health issues and related problems in the workplace and homes of

healthcare workers. Familiarity with non-pharmacological & pharmacological interventions to mitigate mental health issues in at risk

Healthcare Workers.

11:05-11:15am Break 11:15-11:30am FSHP Board Recognitions/President Elect Installation-FSHP President, Bill Kernan, Pharm.D., FASHP

11:30am-12:30pm 1.0 hour of GCE/CRC/Tech for pharmacists and technicians ACPE UAN 0163-0000-020-113-L04-P/T Trauma Informed Care: Overcoming Clinical Inertia Speaker: Jacintha Cauffield, Pharm.D., BCPS, CDE, CRPS-A Associate Professor of Pharmacy, Palm Beach Atlantic College of Pharmacy, West Palm Beach, FL Pharmacist and Technician Objectives: Recognize the widespread impact of trauma on health and mental health. Identify common causes for re-traumatization within healthcare settings. Describe the importance of improving communication with patients and team-based care when working with patients

who have experienced trauma.

12:30pm Closing Remarks-Jeff Bush, Pharm.D., CPh, FSHP President 2020-2021

HOT TOPICS IN PHARMACY 3.0 HOURS OF C.E. M

eeti

ng

Age

nd

a

S

un

day

, Au

gust

9, 2

02

0

2019-2020 Officers and Board of Directors William Kernan, President Sandy Estrada, Immediate Past President Jeff Bush, President Elect Patrick Barnes, Treasurer Charzetta James, Treasurer Elect Kelly Owens, Board of Directors Patricia Louzon, Board of Directors Calvin Tucker, Board of Directors Jordan Wallace, Student Director John Armitstead, Chair of the House of Delegates

Staff

Tamekia Bennett, Operations Director

Brooke Ferrell, Administrative and Member Services Coordinator Kevin Taylor, Communications Consultant

Jeremy Lund, Chair Elect Gary Dalin, Board or Directors Karen Sando, Board of Directors Michael Schuh, Board of Directors Melissa Ruble, Board Elect Dave Lacknauth, Board Elect Hoda Askari, Board Elect Sandra Barnes, Technician Director Jacqueline Champagne, Technician Director Elect David Mackarey, FPA

Acknowledgements

FSHP Council Leadership

Educational Affairs Council Nicole Reardon, Chair John Allen, Vice Chair

Michael Schuh, Board Liaison Kelly Owens, Board Liaison

Legal and Regulatory Affairs Council Kathy Baldwin, Chair

Dorinda Segovia, Vice Chair Dave Harlow, Immediate Past Chair

John Armitstead, Board Liaison

Member Affairs Council Stacey Maravent, Chair

Matthew Curran, Vice Chair Melissa Ruble, Board Liaison

Professional Affairs Council Lindsey Childs Kean, Chair Kristie Zappas, Vice Chair Gary Dalin, Board Liaison Hoda Askari, Board Liaison

Technician Affairs Council Anessia Ellerson, Chair

Charita Barrios, Vice Chair Sandra Barnes, Board Liaison

Jacqueline Champagne, Board Liaison

Research and Education Foundation Board Connie Hogrefe, Chair

Steve Kessinger, Treasurer Alissa Fuller

Thomas Burnakis Dionis Malo

Katlynd Sunjic Amy Birch

Recognitions Past Presidents 1947-48 Anna D. Thiel 1948-49 Charles B. Barnett 1949-50 Margaret K. Tripplett 1950-51 George Lill 1951-52 Lewis Bevis 1952-53 Anna D. Thiel 1953-54 Anna D. Thiel 1954-55 Anna D. Thiel 1955-56 Mary Wernersbach 1956-57 Dwight L. Ferguson 1958-59 Allen Ford 1959-60 Weldon R. Rehburg 1961-62 Irvine D. Williams, Jr. 1962-63 Alfred Reinhardt 1963-64 Frank Drescher 1964-65 Donald S. Owsley 1965-66 Joseph M. Campo 1966-67 Paul Magalian 1967-68 Paul Magalian 1968-69 William G. Blasingame 1969-70 John Ebel 1970-71 Eugene Lane 1971-72 Robert L. Lantos 1972-73 Roger Lapp 1973-74 Haynes A. McDaniel Jr. 1974-75 John L. Walker 1975-76 Rodney Ashbaugh 1976-77 William Thomas 1977-78 Charles M. Shoff 1978-79 William J. Johnson 1979-80 M. Peter Pevonka 1980-81 Gary Dalin 1981-82 William O. Smith 1982-83 David J. Osterberger

1983-84 Joe Ciezkowski 1984-85 Reba Taylor 1985-86 Deborah Klapp 1986-87 Walter Edgerton 1987-88 Paul Pfeiffer 1988-89 Stuart Morris 1989-90 Steve Simmons 1990-91 Stanley Freeman 1991-92 Wayne Russell 1992-93 Carsten Evans 1993-94 Mike Magee 1994-95 James Baker 1995-96 Philip Johnson 1996-97 Mike Clark 1997-98 Deborah Brown 1998-99 John E. Clark 1999-00 David Osterberger 2000-01 Dan Buffington 2001-02 Michele Weizer 2002-03 Rena Coll 2003-04 Thomas Johns 2004-05 Stephen Kessinger 2005-06 Risa Rahm 2006-07 Thomas Burnakis 2007-08 Tina Gegeckas 2008-09 Richard Montgomery 2009-10 R. Peter Iafrate 2010-11 Alissa Fuller 2011-12 Venessa S. Price-Goodnow 2012-2013 Connie Hogrefe 2013-2014 E. Richard Kessler 2014-2015 Tina Gegeckas 2015-2016 Tom Johns 2016-2017 Kathy Baldwin 2017-2018 Charzetta James 2018-2019 Sandy Estrada

Pharmacist of the Year Recipients 1972 Paul Magalian 1988 David Osterberger 1973 Robert L. Lantos 1989 Robert Feinberg 1974 John Ebel 1990 Bob Williams 1975 Roger Lapp 1991 Paul Pfeiffer 1976 Eugene Lane 1992 Tom Keith 1977 Haynes McDaniel, Jr. 1993 Maurice Prusia 1978 William Thomas, Sr. 1994 Stanley Freeman 1979 William J. Bowen 1995 Wayne Russell 1980 Charles M. Shoff 1996 Steve Simmons 1981 Gerry Weinstein 1997 Mike McQuone 1982 M. Peter Pevonka 1998 Philip Johnson 1983 Thomas Baumgartner 1999 Carsten Evans 1984 Jim Powers 2000 Mike Magee 1985 Gary Dalin 2001 Michael Hayes 1986 Monroe Mack 2002 Dan Buffington 1987 William O. Smith 2003 Michele Weizer

Pharmacy Technician of the Year Recipients

1993 Mary Poster 1994 Jeannie Pappas 1995 Vince Adamitis 1996 B.J. Kranz 1997 Dennis Bidwell 1998 Susan Baldwin 1999 Matthew Smith 2000 No recipient 2001 Roy C. Roderick, Jr. 2002 Teresa Reisig

2003 Barry Marshall 2004 no recipient 2005 Patty Smith 2006 Maria Miranda 2007 Debbie Garcia 2008 Omar Tarancon 2009 Carole Simmons-DeCort2010 no recipient2011 Gail Brown

2004 Rena Coll 2005 Thomas Johns 2006 Tony Frezza 2007 Stephen Kessinger 2008 R. Peter Iafrate, Jr. 2009 Ed Hamilton 2010 Deborah Brown 2011 Richard Montgomery 2012 Suzanne Turner 2013 Venessa Price Goodnow 2014 Amy Birch 2015 Connie Hogrefe 2016 Tina Gegeckas 2017 Norm Tomaka 2018 Kathy Baldwin 2019 Karen Sando

2012 Sandra Barnes 2013 Sheryl MacKenzie 2014 Roma Merrick 2015 Zipporah Redding 2016 Danielle Baldwin 2017 Jennifer Jaranilla 2018 Anessia Ellerson 2019 Amanda Teckenbrock

August 6-8, 2021 Rosen Centre, Orlando, FL

August 5-7, 2022 Walt Disney World Swan and Dolphin Resort, Orlando, FL

August 4-6, 2023 Gaylord Palms and Resort, Kissimmee, FL

T Y F A ... S Y A O N M !

Pre-Recorded 'On-Demand' Tracks/Sessions:

Human Trafficking 1.0 hour of CE for pharmacists and technicians

Best Practice Showcase 1.0 hour of CE for pharmacists and technicians

Internal Medicine Track 3.0 hours of CE for pharmacists

Special Populations Track 3.0 hours of CE for pharmacists

Pain Management Track 3.0 hours of CE for pharmacists

 

The Tracks/Sessions in this section are pre-recorded and approved for General and/or Consultant Re-certification Credits  

P -R S C C T LIVE CE R

Three-Part Presentation: 1.0 hour ACPE UAN 0163-0000-020-H04-P/TPart 1: Impact of a Pharmacy Anticoagulation Service in the Emergency Department for Low-Risk Venous Thromboembolism Patients Speaker 1: Cam-Tu Nguyen, Pharm.D. Internal Medicine Clinical Pharmacist, UF Health Jacksonville, Jacksonville, FL Speaker 2: Kristen Heiner, Pharm.D., BCPS Emergency Medicine Clinical Pharmacist, UF Health Jacksonville, Jacksonville, FL Pharmacist Objectives: Demonstrate the need for expanding pharmacist-driven anticoagulation services in the emergency department. Assess the ability of pharmacists to positively impact the care of acute venous thromboembolism patients in theemergency department.

Part 2: The Evolution and Impact of an Innovative Pharmacy Transitions of Care (PTOC) Program on 30-day All Cause Readmission Rates in a Large Health System Speaker 1: Rachel Comer, Pharm.D., MS, BCGP Transitions of Care Pharmacist, BayCare Health System, Safety Harbor, FL Speaker 2: Mary Lomberk, Pharm.D., BCACP Transitions of Care Pharmacist, BayCare Health System, Tampa, FL Pharmacist and Technician Objectives: Describe the development of a novel pharmacist-led transitions of care program. Review 30-day readmission outcomes data for a pharmacist-led transitions of care program.

Part 3: Reimbursement for Pharmacist Services within a Primary Care Office Speaker 1: Julia Nickerson-Troy, Pharm.D., MS, BCACP Manager, Clinical Pharmacy Services, AdventHealth Celebration, Celebration, FL Speaker 2: Lynn Truong, Pharm.D. PGY2 Ambulatory Care Resident, AdventHealth Celebration, Champions Gate, FL Pharmacist and Technician Objectives: Describe opportunities and successes in billing for outpatient pharmacist clinical services. Identify billing requirements required to bill for services. Discuss challenges that occurred during implementation of the outpatient billing procedure.

Human Trafficking - the sexual exploitation or forced labor of another person 1.0 hour ACPE UAN 0163-0000-020-074-H04-P/TSpeaker: Joseph Scuro, J.D., D.C., Pharm.D., MSL, CPM, CPH Healthcare Consultant/Independent Medication Therapy Management Service Provider Pharmacist and Technician Objectives: Describe the scope, incidence, and types of human trafficking in Florida. Recognize key warning signs and risk factors for subjection to human trafficking. Discuss strategies to approach trafficking victims and determine appropriate interventions. Outline procedures for reporting Florida human trafficking. Identify community resources for legal and social services.

P

RE

-RE

CO

RD

ED

SE

SS

ION

S

BEST PRACTICE SHOWCASE 1.0 HOUR OF C.E. FOR PHARMACISTS AND TECHNICIANS

HUMAN TRAFFICKING 1.0 HOUR OF C.E. FOR PHARMACISTS AND TECHNICIANS

CEBroker Tracking #20-778518

Implications of Immunizations: An Update and the Pharmacist’s Role Speaker: Elias Chahine, Pharm.D., FCCP, FASCP, FFSHP, BCPS, BCIDP Professor of Pharmacy Practice, Palm Beach Atlantic University, West Palm Beach, FL Pharmacist Objectives: Develop an understanding of recent epidemiologic changes, etiology, risk factors, and clinical presentation of common

vaccine-preventable diseases. Distinguish between the various available influenza, pneumococcal, herpes zoster, tetanus diphtheria pertussis, measles

mumps rubella, and hepatitis vaccines. Design a patient-specific immunization regimen based on age, risk factors, comorbid conditions, and for special popula-

tions. Justify the role of the pharmacist in immunization and delivery.

Direct Oral Anticoagulants in the Elderly and Special Populations 1.0 hour ACPE UAN 0163-0000-020-116-H01-PSpeaker: Augustus R. Hough, Pharm.D., BCPS (AQ-Cardiology) Clinical Pharmacy Specialist, Cardiology, West Palm Beach VA Medical Center, Stuart, FL Pharmacist Objectives: List selected clinical characteristics, or scenarios, where direct oral anticoagulant (DOAC) use requires additional

consideration. Describe the pharmaco-dynamic and/or -kinetic impact(s) of these considerations. Analyze, and estimate when able, the effects of these considerations on clinical outcomes with DOAC therapy. Develop a reasonable therapeutic plan for anticoagulation when presented with a patient in one of these selected special

populations.

Clinical Pathway Creation: Implementing Best Practices for High Cost Medications. Navigating the Costs, Benefits, and Restrictions 1.0 hour ACPE UAN 0163-0000-020-117-H04-PSpeaker: John Dougherty, MBS, Pharm.D. Associate Professor of Pharmacy, Director of Pharm.D./MBA Program, Llyod L. Gregory School of Pharmacy, Palm Beach Atlantic University, Jupiter, FL Pharmacist Objectives: Describe a systematic approach to manage high cost medications in a health system. Provide clinical evidence to assist with formulary management measures. Provide an example of a medication utilization evaluation identifying a high cost medication and data to support the

assessment. Discuss the role of clinical pharmacy services to promote evidence-based medication utilization initiatives.

INTERNAL MEDICINE TRACK 3.0 HOURS OF C.E.

1.0 hour ACPE UAN 0163-0000-020-115-H01-P/T

Updates in the Oncology Care Model: Where are we now? 1.0 hour ACPE UAN 0163-0000-020-118-H04-PSpeaker: Amanda Brahim Pharm.D., BCOP, BCPS, BCACP Clinical Pharmacy Manager, Hematology/Oncology, Memorial Cancer Institute, Sunrise, FL Pharmacist Objectives: Define the Oncology Care Model (OCM) and its key practice requirements. Describe policies and processes that impact adherence to OCM quality metrics and practice transformation

requirements. Review OCM successes and discuss how to interpret quality measurements for progress assessment. Identify implementation challenges such as measure reporting, data analysis, electronic medical record use, billing

timing, prediction of target pricing, episode identification, and healthcare provider engagement. Propose the role of the clinical pharmacist in the OCM.

Biosimilars: Beyond the Scientific Review 1.0 hour ACPE UAN 0163-0000-020-119-H01-PSpeaker: Jorge J. Garcia, Pharm.D., MS, MHA, MBA, FACHE Assistant Vice President, Pharmacy Services, Baptist Health South Florida, Miami Lakes, FL Pharmacist Objectives: Describe biologic cost trends. Review biosimilars background and market penetration in the US and abroad. Discuss biosimilar manufacturing and approval process. Describe biosimilar industry barriers of entry. Evaluate biosimilar launch and practice implementation challenges. Review potential biosimilar economic impact in the US.

Management of Oncological Emergencies 1.0 hour ACPE UAN 0163-0000-020-120-H01-PSpeaker: Jessica Unzaga, Pharm.D., BCPS, BCOP Clinical Pharmacy Coordinator, Miami Cancer Institute, Baptist, Health South Florida, Miami, FL Pharmacist Objectives: Review the pathophysiology, clinical presentation and diagnosis for types of oncologic emergencies including febrile

neutropenia, hypercalcemia of malignancy, tumor lysis syndrome, superior vena cava syndrome, spinal cordcompression and acute promyelocytic leukemia.

Outline the appropriate pharmacologic and non‐pharmacologic treatment of patients presenting with an oncologicemergency.

Apply the clinical data supporting therapeutic treatment recommendations for implementation of an individualizedtreatment plan for patients presenting with an oncologic emergency.

P

RE

-RE

CO

RD

ED

SE

SS

ION

SSPECIAL POPULATIONS: ONCOLOGY TRACK 3.0 HOURS OF C.E. FOR PHARMACISTS

Smooth Sailing or Bumpy Ride: Regulatory and Clinical Challenges of Pain Management Speaker 1: Dina Dumercy McHenry, Pharm.D. Director of Pharmacy, Miami Cancer Institute, Baptist Health South Florida, Pembroke Pines, FL Speaker 2: Leonette Kemp, Pharm.D. Pharmacy Clinical Specialist, Baptist Hospital Miami, Miami Cancer Institute, Miami, FL Pharmacist Objectives: Part 1: Putting Controls on the Controls Update and review current federal and state regulations on prescribing and dispensing controlled substances. Review the Joint Commission Medication Management Standards on pain management and discuss the requirements to

achieve compliance within the health system setting. Describe potential areas for controlled substance diversion within the health system and available solutions to mitigate

diversion risk.

Pharmacist Objectives: Part 2: Adjusting the Sails on our Clinical Approach to Pain Describe the pathophysiology of acute and chronic pain. Discuss pharmacologic and non-pharmacologic options for pain management. Define opioid use disorder (OUD) and describe OUD screening techniques. Discuss the role of the pharmacist in assisting with the management of OUD patients.

Relieving the Agony without Full Agonists: The Role of Multi-modal Opioids, Neuropathic, and Topical Agents for Chronic Pain Patients 1.0 hour ACPE UAN 0163-0000-020-122-H01-PSpeaker: Michelle Krichbaum, Pharm.D. Assistant Professor, Nova Southeastern University College of Pharmacy, Sunrise, FL Pharmacist Objectives: Compare types of pain (e.g. nociceptive vs. neuropathic, acute vs. chronic). Differentiate full opioid agonists from multi-modal and partial agonists (e.g. methadone, buprenorphine, tramadol,

tapentadol), and the role they play in chronic pain management. Discuss gabapentinoids and SNRIs and their role in chronic pain. Evaluate the efficacy of various topical analgesics and their role in chronic pain.

Pain Management in Special Populations: A Focus on Pediatric and Geriatric Pain 1.0 hour ACPE UAN 0163-0000-020-123-H01-PSpeaker 1: Pediatrics – Ashley Siryk, Pharm.D. Clinical Pharmacy Specialist, Joe DiMaggio Children’s Hospital, Ft. Lauderdale, FL Speaker 2: Geriatrics – Sylvia Tran, Pharm.D. Clinical Pharmacy Specialist, Pain, North Florida/South Georgia Veterans Health System, Gainesville, FL Pharmacist Objectives: Differentiate pain assessment techniques in pediatric and geriatric patients Discuss medication selection and dosing considerations in pediatric and geriatric populations. Review techniques for managing adverse drug reactions related to pain medications in these populations. Review complementary approaches to pain management.

PAIN MANAGEMENT TRACK 3.0 HOURS OF C.E. FOR PHARMACISTS

1.0 hour ACPE UAN 0163-0000-020-121-H04-P